Market Closed -
NSE India S.E.
05:13:46 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
990.2
INR
|
-0.73%
|
|
+5.53%
|
+30.40%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,01,386
|
1,00,715
|
1,89,674
|
1,45,771
|
97,564
|
1,94,647
|
-
|
-
|
Enterprise Value (EV)
1 |
1,08,614
|
1,17,382
|
1,90,614
|
1,52,248
|
1,03,100
|
1,97,263
|
1,94,189
|
1,91,167
|
P/E ratio
|
17.3
x
|
12.1
x
|
15.9
x
|
26.7
x
|
28.5
x
|
32.8
x
|
27.6
x
|
22.9
x
|
Yield
|
1.02%
|
1.31%
|
1.45%
|
1.35%
|
1.61%
|
0.9%
|
1.02%
|
1.13%
|
Capitalization / Revenue
|
2.58
x
|
2.19
x
|
3.52
x
|
2.75
x
|
1.73
x
|
3.07
x
|
2.77
x
|
2.5
x
|
EV / Revenue
|
2.76
x
|
2.55
x
|
3.53
x
|
2.87
x
|
1.82
x
|
3.11
x
|
2.76
x
|
2.46
x
|
EV / EBITDA
|
12.4
x
|
9.6
x
|
12.2
x
|
17.4
x
|
14.6
x
|
21.1
x
|
16.6
x
|
13.9
x
|
EV / FCF
|
68.7
x
|
-52.5
x
|
23.7
x
|
120
x
|
36.8
x
|
45.9
x
|
38.2
x
|
31.4
x
|
FCF Yield
|
1.45%
|
-1.9%
|
4.22%
|
0.83%
|
2.72%
|
2.18%
|
2.62%
|
3.18%
|
Price to Book
|
3.73
x
|
3.13
x
|
3.7
x
|
2.79
x
|
2.23
x
|
4.11
x
|
3.69
x
|
3.31
x
|
Nbr of stocks (in thousands)
|
1,88,520
|
1,88,516
|
1,96,563
|
1,96,563
|
1,96,563
|
1,96,563
|
-
|
-
|
Reference price
2 |
537.8
|
534.2
|
965.0
|
741.6
|
496.4
|
990.2
|
990.2
|
990.2
|
Announcement Date
|
08/05/19
|
23/04/20
|
04/05/21
|
02/05/22
|
05/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
39,347
|
46,058
|
53,931
|
53,058
|
56,526
|
63,378
|
70,383
|
77,775
|
EBITDA
1 |
8,736
|
12,230
|
15,576
|
8,742
|
7,084
|
9,345
|
11,692
|
13,754
|
EBIT
1 |
7,584
|
10,657
|
13,741
|
5,874
|
4,329
|
6,581
|
8,660
|
10,475
|
Operating Margin
|
19.27%
|
23.14%
|
25.48%
|
11.07%
|
7.66%
|
10.38%
|
12.3%
|
13.47%
|
Earnings before Tax (EBT)
1 |
7,493
|
9,998
|
13,681
|
6,201
|
3,855
|
6,242
|
8,452
|
10,279
|
Net income
1 |
5,844
|
8,291
|
11,781
|
5,457
|
3,420
|
5,917
|
7,029
|
8,395
|
Net margin
|
14.85%
|
18%
|
21.84%
|
10.28%
|
6.05%
|
9.34%
|
9.99%
|
10.79%
|
EPS
2 |
31.00
|
43.98
|
60.81
|
27.76
|
17.40
|
30.22
|
35.93
|
43.16
|
Free Cash Flow
1 |
1,580
|
-2,235
|
8,039
|
1,267
|
2,805
|
4,300
|
5,088
|
6,084
|
FCF margin
|
4.02%
|
-4.85%
|
14.91%
|
2.39%
|
4.96%
|
6.78%
|
7.23%
|
7.82%
|
FCF Conversion (EBITDA)
|
18.09%
|
-
|
51.61%
|
14.5%
|
39.6%
|
46.01%
|
43.51%
|
44.24%
|
FCF Conversion (Net income)
|
27.04%
|
-
|
68.23%
|
23.22%
|
82.03%
|
72.67%
|
72.38%
|
72.47%
|
Dividend per Share
2 |
5.500
|
7.000
|
14.00
|
10.00
|
8.000
|
8.888
|
10.06
|
11.15
|
Announcement Date
|
08/05/19
|
23/04/20
|
04/05/21
|
02/05/22
|
05/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
13,143
|
12,804
|
13,260
|
12,923
|
12,717
|
14,157
|
12,621
|
14,750
|
15,090
|
14,064
|
14,862
|
15,448
|
16,275
|
16,060
|
EBITDA
1 |
3,651
|
3,417
|
2,359
|
2,572
|
2,557
|
1,601
|
146.5
|
2,327
|
2,488
|
2,122
|
1,987
|
2,452
|
2,444
|
2,606
|
EBIT
|
3,181
|
-
|
-
|
-
|
1,997
|
370.2
|
-
|
1,650
|
1,822
|
1,381
|
-
|
-
|
1,536
|
1,706
|
Operating Margin
|
24.2%
|
-
|
-
|
-
|
15.7%
|
2.61%
|
-
|
11.19%
|
12.08%
|
9.82%
|
-
|
-
|
9.44%
|
10.62%
|
Earnings before Tax (EBT)
1 |
3,183
|
2,919
|
1,826
|
2,002
|
1,967
|
405.9
|
-601.6
|
1,530
|
1,681
|
1,246
|
1,298
|
1,587
|
1,680
|
1,695
|
Net income
1 |
2,926
|
2,507
|
1,645
|
1,693
|
1,764
|
354.6
|
-658.8
|
1,334
|
1,219
|
1,526
|
1,206
|
1,470
|
1,413
|
1,467
|
Net margin
|
22.26%
|
19.58%
|
12.41%
|
13.1%
|
13.87%
|
2.5%
|
-5.22%
|
9.04%
|
8.08%
|
10.85%
|
8.11%
|
9.51%
|
8.68%
|
9.14%
|
EPS
|
14.88
|
12.75
|
8.370
|
8.610
|
8.980
|
1.800
|
-
|
6.780
|
6.200
|
-
|
-
|
-
|
5.250
|
6.000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/01/21
|
04/05/21
|
26/07/21
|
10/11/21
|
10/02/22
|
02/05/22
|
04/08/22
|
11/11/22
|
01/02/23
|
05/05/23
|
04/08/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
7,228
|
16,667
|
941
|
6,477
|
5,536
|
2,617
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
457
|
3,479
|
Leverage (Debt/EBITDA)
|
0.8274
x
|
1.363
x
|
0.0604
x
|
0.7409
x
|
0.7815
x
|
0.28
x
|
-
|
-
|
Free Cash Flow
1 |
1,580
|
-2,235
|
8,039
|
1,267
|
2,805
|
4,300
|
5,088
|
6,084
|
ROE (net income / shareholders' equity)
|
23.7%
|
27.9%
|
28.2%
|
10.5%
|
7.12%
|
12.8%
|
14.2%
|
15.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
18.6%
|
7.89%
|
5.14%
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
63,489
|
69,152
|
66,525
|
-
|
-
|
-
|
Book Value Per Share
2 |
144.0
|
171.0
|
261.0
|
266.0
|
222.0
|
241.0
|
268.0
|
300.0
|
Cash Flow per Share
2 |
43.10
|
23.80
|
75.50
|
27.60
|
36.80
|
42.80
|
45.00
|
40.40
|
Capex
1 |
6,539
|
6,726
|
6,595
|
4,256
|
4,434
|
3,297
|
3,058
|
3,327
|
Capex / Sales
|
16.62%
|
14.6%
|
12.23%
|
8.02%
|
7.84%
|
5.2%
|
4.35%
|
4.28%
|
Announcement Date
|
08/05/19
|
23/04/20
|
04/05/21
|
02/05/22
|
05/05/23
|
-
|
-
|
-
|
Last Close Price
990.2
INR Average target price
937.7
INR Spread / Average Target -5.31% Consensus |
1st Jan change
|
Capi.
|
---|
| +30.40% | 2.33B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|